6.47
0.00
(0.00%)
At close: April 1 at 4:00:00 PM EDT
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Revenue
448,269
448,269
1,492,761
19,374,904
510,624
Cost of Revenue
181,516
181,516
684,456
1,072,221
67,180
Gross Profit
266,753
266,753
808,305
18,302,683
443,444
Operating Expense
791,054
791,054
1,269,159
748,449
227,637
Operating Income
-524,301
-524,301
-460,854
17,554,234
215,807
Net Non Operating Interest Income Expense
82,854
82,854
189,554
99,732
477
Other Income Expense
288,413
288,413
296,538
-90,925
333
Pretax Income
-153,034
-153,034
25,238
17,563,041
216,617
Tax Provision
105,321
105,321
-62,893
3,104,130
31,438
Net Income Common Stockholders
-105,900
-105,900
107,884
8,461,498
104,354
Diluted NI Available to Com Stockholders
-105,900
-105,900
107,884
8,461,498
104,354
Basic EPS
-3.62
-1.06
1.08
85.20
1.06
Diluted EPS
-3.62
-1.06
1.00
74.27
0.97
Basic Average Shares
99,539.42
99,607.57
99,502.24
99,311.55
98,897.35
Diluted Average Shares
114,200.03
99,607.57
114,172.78
114,005.98
113,662.36
Total Operating Income as Reported
-603,021
-603,021
-466,067
17,553,257
215,644
Rent Expense Supplemental
778
778
819
851
798
Total Expenses
972,570
972,570
1,953,615
1,820,670
294,817
Net Income from Continuing & Discontinued Operation
-99,918
-99,918
113,866
8,467,480
110,369
Normalized Income
-40,878
-40,878
117,775.75
8,468,284.32
110,508.34
Interest Income
85,114
85,114
190,818
102,568
1,930
Interest Expense
2,260
2,260
1,264
2,836
1,453
Net Interest Income
82,854
82,854
189,554
99,732
477
EBIT
-150,774
-150,774
26,502
17,565,877
218,070
EBITDA
-6,029
-6,029
183,099
17,652,709
222,107
Reconciled Cost of Revenue
181,516
181,516
684,456
1,072,221
67,180
Reconciled Depreciation
144,745
144,745
156,597
86,832
4,037
Net Income from Continuing Operation Net Minority Interest
-99,918
-99,918
113,866
8,467,480
110,369
Total Unusual Items Excluding Goodwill
-78,720
-78,720
-5,213
-977
-163
Total Unusual Items
-78,720
-78,720
-5,213
-977
-163
Normalized EBITDA
72,691
72,691
188,312
17,653,686
222,270
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-19,680
-19,680
-1,303.25
-172.68
-23.66
12/31/2020 - 9/26/2003
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
OPT Opthea Limited
3.4100
+1.49%
WINTW WINDTREE THERAPEUTICS INC C/WTS
0.0070
+100.00%
ESLAW Estrella Immunopharma, Inc.
0.0885
+5.11%
APLMW Apollomics, Inc.
0.0096
+23.08%
LIXTW Lixte Biotechnology Holdings, Inc.
0.0388
+83.89%
COEPW Coeptis Therapeutics Holdings, Inc.
0.0074
+45.10%
TCBWF TC Biopharm (Holdings) Plc
0.0026
0.00%
OSRHW OSR Holdings, Inc.
0.0389
+24.68%
CEROW CERo Therapeutics Holdings, Inc.
0.0143
+1.42%
MMIRF MedMira Inc.
0.0207
0.00%